The emergence and successful elimination of SARS-CoV-2 dominant strains with increasing epidemic potential in Taiwan’s 2021 outbreak
Taiwan’s experience with severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 guided its development of strategies to defend against SARS-CoV-2 in 2020, which enabled the successful control of Coronavirus disease 2019 (COVID-19) cases from 2020 through March 2021. However, in late-April...
Saved in:
Published in | Heliyon Vol. 9; no. 12; p. e22436 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.12.2023
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Taiwan’s experience with severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 guided its development of strategies to defend against SARS-CoV-2 in 2020, which enabled the successful control of Coronavirus disease 2019 (COVID-19) cases from 2020 through March 2021. However, in late-April 2021, the imported Alpha variant began to cause COVID-19 outbreaks at an exceptional rate in Taiwan. In this study, we aimed to determine what epidemiological conditions enabled the SARS-CoV-2 Alpha variant strains to become dominant and decline later during a surge in the outbreak. In conjunction with contact-tracing investigations, we used our bioinformatics software, CoVConvert and IniCoV, to analyze whole-genome sequences of 101 Taiwan Alpha strains. Univariate and multivariable regression analyses revealed the epidemiological factors associated with viral dominance. Univariate analysis showed the dominant Alpha strains were preferentially selected in the surge’s epicenter (p = 0.0024) through intensive human-to-human contact and maintained their dominance for 1.5 months until the Zero-COVID Policy was implemented. Multivariable regression found that the epidemic periods (p = 0.007) and epicenter (p = 0.001) were two significant factors associated with the dominant virus strains spread in the community. These dominant virus strains emerged at the outbreak’s epicenter with frequent human-to-human contact and low vaccination coverage. The Level 3 Restrictions and Zero-COVID policy successfully controlled the outbreak in the community without city lockdowns. Our integrated method can identify the epidemiological conditions for emerging dominant virus with increasing epidemiological potential and support decision makers in rapidly containing outbreaks using public health measures that target fast-spreading virus strains.
This figure summarizes our major findings in this study. Before the outbreak (T0, Pre-outbreak), the imported Alpha variant strains were heterogeneous with high viral genome divergence. However, such diversity significantly decreased during the T1 period (versus T0, p < 0.0001), when the dominant virus strains with selective advantages appeared. We also investigated the epidemiological conditions in Taiwan that facilitated the emergence of the predominant virus strain in the T1 period. The effective reproductive numbers over time (Rt) for the viruses from the imported cases were all zero at T0 period before the outbreak. However, the mean Rt values of the viruses from the pilots to quarantine hotel staff and subsequent dominant virus strains in the community (i.e. same sequence identities as the ID-3445/1263/1186) increased rapidly. Specific epidemiological conditions, including unmasked dining in many teahouses, and customers’ movement across teahouses, helped the dominant Alpha variant strains with a selective advantage. This study demonstrated that natural selection of a dominant virus strain (prior to immune selection) progressed in three stages: (1) selection started from a diverse virus pool (i.e. imported viruses at T0), (2) selection advantages increased through virus replication, in which the progeny virus had more advantages than its parent virus, and (3) selection of a fast-spreading virus strain through human-to-human transmission when a community had suitable epidemiological conditions (i.e. our T1 period and epicenter). Most importantly, COVID-19 cases dropped sharply alongside the two important population-intervention strategies (Level 3 Restrictions and Zero-COVID policy). [Display omitted]
•Frequent human-to-human contact at the epicenter selected dominant SARS-CoV-2 strains.•Dominant SARS-CoV-2 strains had the highest Rt values under specific epidemiological conditions.•Level 3 Restrictions and Zero-COVID Policy were effective without lockdown.•Individual- and population-based prevention measures contained fast-spreading dominant virus strains.•Preventing cluster cases that would have aided viral selection effectively defended against VOCs. |
---|---|
AbstractList | Taiwan’s experience with severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 guided its development of strategies to defend against SARS-CoV-2 in 2020, which enabled the successful control of Coronavirus disease 2019 (COVID-19) cases from 2020 through March 2021. However, in late-April 2021, the imported Alpha variant began to cause COVID-19 outbreaks at an exceptional rate in Taiwan. In this study, we aimed to determine what epidemiological conditions enabled the SARS-CoV-2 Alpha variant strains to become dominant and decline later during a surge in the outbreak. In conjunction with contact-tracing investigations, we used our bioinformatics software, CoVConvert and IniCoV, to analyze whole-genome sequences of 101 Taiwan Alpha strains. Univariate and multivariable regression analyses revealed the epidemiological factors associated with viral dominance. Univariate analysis showed the dominant Alpha strains were preferentially selected in the surge’s epicenter (p = 0.0024) through intensive human-to-human contact and maintained their dominance for 1.5 months until the Zero-COVID Policy was implemented. Multivariable regression found that the epidemic periods (p = 0.007) and epicenter (p = 0.001) were two significant factors associated with the dominant virus strains spread in the community. These dominant virus strains emerged at the outbreak’s epicenter with frequent human-to-human contact and low vaccination coverage. The Level 3 Restrictions and Zero-COVID policy successfully controlled the outbreak in the community without city lockdowns. Our integrated method can identify the epidemiological conditions for emerging dominant virus with increasing epidemiological potential and support decision makers in rapidly containing outbreaks using public health measures that target fast-spreading virus strains. Taiwan's experience with severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 guided its development of strategies to defend against SARS-CoV-2 in 2020, which enabled the successful control of Coronavirus disease 2019 (COVID-19) cases from 2020 through March 2021. However, in late-April 2021, the imported Alpha variant began to cause COVID-19 outbreaks at an exceptional rate in Taiwan. In this study, we aimed to determine what epidemiological conditions enabled the SARS-CoV-2 Alpha variant strains to become dominant and decline later during a surge in the outbreak. In conjunction with contact-tracing investigations, we used our bioinformatics software, CoVConvert and IniCoV, to analyze whole-genome sequences of 101 Taiwan Alpha strains. Univariate and multivariable regression analyses revealed the epidemiological factors associated with viral dominance. Univariate analysis showed the dominant Alpha strains were preferentially selected in the surge's epicenter (p = 0.0024) through intensive human-to-human contact and maintained their dominance for 1.5 months until the Zero-COVID Policy was implemented. Multivariable regression found that the epidemic periods (p = 0.007) and epicenter (p = 0.001) were two significant factors associated with the dominant virus strains spread in the community. These dominant virus strains emerged at the outbreak's epicenter with frequent human-to-human contact and low vaccination coverage. The Level 3 Restrictions and Zero-COVID policy successfully controlled the outbreak in the community without city lockdowns. Our integrated method can identify the epidemiological conditions for emerging dominant virus with increasing epidemiological potential and support decision makers in rapidly containing outbreaks using public health measures that target fast-spreading virus strains.Taiwan's experience with severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 guided its development of strategies to defend against SARS-CoV-2 in 2020, which enabled the successful control of Coronavirus disease 2019 (COVID-19) cases from 2020 through March 2021. However, in late-April 2021, the imported Alpha variant began to cause COVID-19 outbreaks at an exceptional rate in Taiwan. In this study, we aimed to determine what epidemiological conditions enabled the SARS-CoV-2 Alpha variant strains to become dominant and decline later during a surge in the outbreak. In conjunction with contact-tracing investigations, we used our bioinformatics software, CoVConvert and IniCoV, to analyze whole-genome sequences of 101 Taiwan Alpha strains. Univariate and multivariable regression analyses revealed the epidemiological factors associated with viral dominance. Univariate analysis showed the dominant Alpha strains were preferentially selected in the surge's epicenter (p = 0.0024) through intensive human-to-human contact and maintained their dominance for 1.5 months until the Zero-COVID Policy was implemented. Multivariable regression found that the epidemic periods (p = 0.007) and epicenter (p = 0.001) were two significant factors associated with the dominant virus strains spread in the community. These dominant virus strains emerged at the outbreak's epicenter with frequent human-to-human contact and low vaccination coverage. The Level 3 Restrictions and Zero-COVID policy successfully controlled the outbreak in the community without city lockdowns. Our integrated method can identify the epidemiological conditions for emerging dominant virus with increasing epidemiological potential and support decision makers in rapidly containing outbreaks using public health measures that target fast-spreading virus strains. Taiwan’s experience with severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 guided its development of strategies to defend against SARS-CoV-2 in 2020, which enabled the successful control of Coronavirus disease 2019 (COVID-19) cases from 2020 through March 2021. However, in late-April 2021, the imported Alpha variant began to cause COVID-19 outbreaks at an exceptional rate in Taiwan. In this study, we aimed to determine what epidemiological conditions enabled the SARS-CoV-2 Alpha variant strains to become dominant and decline later during a surge in the outbreak. In conjunction with contact-tracing investigations, we used our bioinformatics software, CoVConvert and IniCoV, to analyze whole-genome sequences of 101 Taiwan Alpha strains. Univariate and multivariable regression analyses revealed the epidemiological factors associated with viral dominance. Univariate analysis showed the dominant Alpha strains were preferentially selected in the surge’s epicenter (p = 0.0024) through intensive human-to-human contact and maintained their dominance for 1.5 months until the Zero-COVID Policy was implemented. Multivariable regression found that the epidemic periods (p = 0.007) and epicenter (p = 0.001) were two significant factors associated with the dominant virus strains spread in the community. These dominant virus strains emerged at the outbreak’s epicenter with frequent human-to-human contact and low vaccination coverage. The Level 3 Restrictions and Zero-COVID policy successfully controlled the outbreak in the community without city lockdowns. Our integrated method can identify the epidemiological conditions for emerging dominant virus with increasing epidemiological potential and support decision makers in rapidly containing outbreaks using public health measures that target fast-spreading virus strains. This figure summarizes our major findings in this study. Before the outbreak (T0, Pre-outbreak), the imported Alpha variant strains were heterogeneous with high viral genome divergence. However, such diversity significantly decreased during the T1 period (versus T0, p < 0.0001), when the dominant virus strains with selective advantages appeared. We also investigated the epidemiological conditions in Taiwan that facilitated the emergence of the predominant virus strain in the T1 period. The effective reproductive numbers over time (Rt) for the viruses from the imported cases were all zero at T0 period before the outbreak. However, the mean Rt values of the viruses from the pilots to quarantine hotel staff and subsequent dominant virus strains in the community (i.e. same sequence identities as the ID-3445/1263/1186) increased rapidly. Specific epidemiological conditions, including unmasked dining in many teahouses, and customers’ movement across teahouses, helped the dominant Alpha variant strains with a selective advantage. This study demonstrated that natural selection of a dominant virus strain (prior to immune selection) progressed in three stages: (1) selection started from a diverse virus pool (i.e. imported viruses at T0), (2) selection advantages increased through virus replication, in which the progeny virus had more advantages than its parent virus, and (3) selection of a fast-spreading virus strain through human-to-human transmission when a community had suitable epidemiological conditions (i.e. our T1 period and epicenter). Most importantly, COVID-19 cases dropped sharply alongside the two important population-intervention strategies (Level 3 Restrictions and Zero-COVID policy). [Display omitted] •Frequent human-to-human contact at the epicenter selected dominant SARS-CoV-2 strains.•Dominant SARS-CoV-2 strains had the highest Rt values under specific epidemiological conditions.•Level 3 Restrictions and Zero-COVID Policy were effective without lockdown.•Individual- and population-based prevention measures contained fast-spreading dominant virus strains.•Preventing cluster cases that would have aided viral selection effectively defended against VOCs. Taiwan’s experience with severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 guided its development of strategies to defend against SARS-CoV-2 in 2020, which enabled the successful control of Coronavirus disease 2019 (COVID-19) cases from 2020 through March 2021. However, in late-April 2021, the imported Alpha variant began to cause COVID-19 outbreaks at an exceptional rate in Taiwan. In this study, we aimed to determine what epidemiological conditions enabled the SARS-CoV-2 Alpha variant strains to become dominant and decline later during a surge in the outbreak. In conjunction with contact-tracing investigations, we used our bioinformatics software, CoVConvert and IniCoV, to analyze whole-genome sequences of 101 Taiwan Alpha strains. Univariate and multivariable regression analyses revealed the epidemiological factors associated with viral dominance. Univariate analysis showed the dominant Alpha strains were preferentially selected in the surge’s epicenter (p = 0.0024) through intensive human-to-human contact and maintained their dominance for 1.5 months until the Zero-COVID Policy was implemented. Multivariable regression found that the epidemic periods (p = 0.007) and epicenter (p = 0.001) were two significant factors associated with the dominant virus strains spread in the community. These dominant virus strains emerged at the outbreak’s epicenter with frequent human-to-human contact and low vaccination coverage. The Level 3 Restrictions and Zero-COVID policy successfully controlled the outbreak in the community without city lockdowns. Our integrated method can identify the epidemiological conditions for emerging dominant virus with increasing epidemiological potential and support decision makers in rapidly containing outbreaks using public health measures that target fast-spreading virus strains. |
ArticleNumber | e22436 |
Author | King, Chwan-Chuen Tung, Tsung-Hua Chan, Ta-Chien Shang, Hung-Sheng Fan, Yi-Chin Huang, Chung-Guei Kao, Chuan-Liang Liu, Wei Chang, Sui-Yuan Hung, Kuo-Sheng Lin, Wan-Yu Yang, Chin-Rur Tsai, Jih-Jin Daisy Liu, Li-Yu Wu, Hui-Lin Ku, Chia-Chi Gong, Yu-Nong |
Author_xml | – sequence: 1 givenname: Chin-Rur orcidid: 0000-0002-0178-7744 surname: Yang fullname: Yang, Chin-Rur organization: Graduate Institute of Immunology, College of Medicine, National Taiwan University, 1 Jen-Ai Road Section 1, Taipei, 10051, Taiwan, ROC – sequence: 2 givenname: Sui-Yuan orcidid: 0000-0002-6009-6724 surname: Chang fullname: Chang, Sui-Yuan organization: Department (Dept.) of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, 10051, Taiwan, ROC – sequence: 3 givenname: Yu-Nong orcidid: 0000-0002-6799-1561 surname: Gong fullname: Gong, Yu-Nong organization: Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan, 33302, Taiwan, ROC – sequence: 4 givenname: Chung-Guei orcidid: 0000-0002-0598-5684 surname: Huang fullname: Huang, Chung-Guei organization: Dept. of Laboratory Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan, 33302, Taiwan, ROC – sequence: 5 givenname: Tsung-Hua orcidid: 0000-0003-4867-5544 surname: Tung fullname: Tung, Tsung-Hua organization: Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, NTU 17 Xu-Zhou Road, Taipei, 10055, Taiwan, ROC – sequence: 6 givenname: Wei orcidid: 0000-0003-2829-4226 surname: Liu fullname: Liu, Wei organization: Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, NTU 17 Xu-Zhou Road, Taipei, 10055, Taiwan, ROC – sequence: 7 givenname: Ta-Chien orcidid: 0000-0002-1685-783X surname: Chan fullname: Chan, Ta-Chien organization: Research Center for Humanities and Social Sciences, Academia Sinica, Taipei, 11529, Taiwan, ROC – sequence: 8 givenname: Kuo-Sheng orcidid: 0000-0002-7643-9218 surname: Hung fullname: Hung, Kuo-Sheng organization: Center for Precision Medicine and Genomics, Tri-Service General Hospital, National Defense Medical Center, Taipei, 11490, Taiwan, ROC – sequence: 9 givenname: Hung-Sheng surname: Shang fullname: Shang, Hung-Sheng organization: Division of Clinical Pathology, Dept. of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, 11490, Taiwan, ROC – sequence: 10 givenname: Jih-Jin orcidid: 0000-0003-2226-8916 surname: Tsai fullname: Tsai, Jih-Jin organization: School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan, ROC – sequence: 11 givenname: Chuan-Liang surname: Kao fullname: Kao, Chuan-Liang organization: Department (Dept.) of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, 10051, Taiwan, ROC – sequence: 12 givenname: Hui-Lin surname: Wu fullname: Wu, Hui-Lin organization: Hepatitis Research Center, National Taiwan University Hospital, Taipei, 10051, Taiwan, ROC – sequence: 13 givenname: Li-Yu surname: Daisy Liu fullname: Daisy Liu, Li-Yu organization: Division of Biometry, Department of Agronomy, National Taiwan University, Taipei, 10617, Taiwan, ROC – sequence: 14 givenname: Wan-Yu orcidid: 0000-0002-3385-4702 surname: Lin fullname: Lin, Wan-Yu organization: Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, NTU 17 Xu-Zhou Road, Taipei, 10055, Taiwan, ROC – sequence: 15 givenname: Yi-Chin orcidid: 0000-0003-1866-0800 surname: Fan fullname: Fan, Yi-Chin organization: Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, NTU 17 Xu-Zhou Road, Taipei, 10055, Taiwan, ROC – sequence: 16 givenname: Chwan-Chuen surname: King fullname: King, Chwan-Chuen email: chwanchuen@gmail.com organization: Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, NTU 17 Xu-Zhou Road, Taipei, 10055, Taiwan, ROC – sequence: 17 givenname: Chia-Chi orcidid: 0000-0002-5740-1505 surname: Ku fullname: Ku, Chia-Chi email: chiachiku@ntu.edu.tw organization: Graduate Institute of Immunology, College of Medicine, National Taiwan University, 1 Jen-Ai Road Section 1, Taipei, 10051, Taiwan, ROC |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38107297$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUstu1DAUjVARLaWfAPKSTQa_k4gFqkY8KlVCogNby3GuZzwk9mA7VN2x4h_4Pb6EpDNFiM2sfOV7zrlX95ynxYkPHoriOcELgol8tV1soHd3wS8opmwBlHImHxVnlGNR1pzjk3_q0-IipS3GmIhaNhV7UpyymuCKNtVZ8XO1AQQDxDV4A0j7DqXRGEjJjj2ahgzO6-yCR8Gim8tPN-UyfCkp6sLc8BmlHLXzCd26vEHOmwg6Ob9GsHMdDM6gXcjgs9P91EUr7W61__3jV0LT5gSFMbcT4-uz4rHVfYKLw3tefH73drX8UF5_fH-1vLwujSAkl6JpRCU4EzURbYeNtphXpOKk4VYyI6AVuiGsq7qGYms7zAVtJRUtFoZY2bLz4mqv2wW9VbvoBh3vVNBO3X-EuFY6Zmd6UIIw1jCLLROSN9romkssiWatlaKlbNJ6udfaxfBthJTV4JKBvtcewpgUI4JVNZkcOAqlDWaMColn1RcH6NgO0P3d8cGyCfB6DzAxpBTBKuPyvUWzE70iWM0ZUVt1yIiaM6L2GZnY4j_2w4BjvDd7HkzufHcQVTJujkznIpg8nc8dUfgDi2TYcA |
CitedBy_id | crossref_primary_10_1016_j_bj_2024_100820 |
Cites_doi | 10.1126/science.abj4336 10.1001/jamainternmed.2021.1644 10.1128/JCM.00741-21 10.3390/v15051194 10.1016/j.epidem.2023.100677 10.1016/j.jmgm.2022.108193 10.1186/s13578-022-00770-1 10.1016/S1473-3099(20)30120-1 10.1126/science.abm1208 10.3201/eid2801.211804 10.1126/science.abq6109 10.1007/s10654-023-00963-z 10.3201/eid2810.220456 10.1016/j.ijid.2009.06.006 10.1038/s41588-022-01033-y 10.1371/journal.pone.0031162 10.3201/eid2806.211821 10.1016/j.ijid.2021.06.002 10.1371/journal.pntd.0009312 10.1186/s12859-020-03650-y 10.1128/mBio.00587-21 10.1371/journal.pntd.0009835 10.1186/s13073-022-01098-8 10.1080/22221751.2020.1782271 10.1186/s12859-021-04017-7 10.1038/s41598-022-16011-x 10.1093/molbev/msg182 10.1038/s41467-023-38435-3 10.2147/IDR.S328327 10.1186/s13059-014-0538-4 10.1002/jmv.28366 10.1016/S2666-5247(21)00121-X 10.1016/j.celrep.2021.110205 10.1136/bmj.o859 10.1371/journal.pntd.0006827 10.1038/s41591-022-01836-w 10.3201/eid2904.221497 10.1186/s12985-022-01896-x |
ContentType | Journal Article |
Copyright | 2023 The Author(s) 2023 The Author(s). |
Copyright_xml | – notice: 2023 The Author(s) – notice: 2023 The Author(s). |
DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 7S9 L.6 DOA |
DOI | 10.1016/j.heliyon.2023.e22436 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic AGRICOLA |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 2405-8440 |
ExternalDocumentID | oai_doaj_org_article_513393f0f35649aca846061a3bf65b23 38107297 10_1016_j_heliyon_2023_e22436 S2405844023096445 |
Genre | Journal Article |
GeographicLocations | Taiwan |
GeographicLocations_xml | – name: Taiwan |
GroupedDBID | 0R~ 457 53G 5VS 6I. AAEDW AAFTH AAFWJ AALRI AAYWO ABMAC ACGFS ACLIJ ACVFH ADBBV ADCNI ADEZE ADVLN AEUPX AEXQZ AFJKZ AFPKN AFPUW AFTJW AGHFR AIGII AITUG AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS APXCP BAWUL BCNDV DIK EBS EJD FDB GROUPED_DOAJ HYE IPNFZ KQ8 M~E O9- OK1 RIG ROL RPM SSZ AAYXX CITATION AACTN NPM 7X8 7S9 L.6 |
ID | FETCH-LOGICAL-c511t-599575435815bd0caf047174194f63c5eb5a913d7d920ffd0452b625b05c1f6b3 |
IEDL.DBID | DOA |
ISSN | 2405-8440 |
IngestDate | Wed Aug 27 01:22:24 EDT 2025 Fri Aug 22 21:00:39 EDT 2025 Fri Jul 11 01:45:07 EDT 2025 Thu Apr 03 07:01:58 EDT 2025 Sun Jul 06 05:05:31 EDT 2025 Thu Apr 24 22:58:05 EDT 2025 Sat Aug 09 17:31:56 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | SARS-CoV-2 Viral variants Whole-genome sequencing Epicenter Transmission Taiwan Spatio-temporal analysis Community outbreak Reproduction number Bioinformatics |
Language | English |
License | This is an open access article under the CC BY license. 2023 The Author(s). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c511t-599575435815bd0caf047174194f63c5eb5a913d7d920ffd0452b625b05c1f6b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-6009-6724 0000-0002-7643-9218 0000-0002-3385-4702 0000-0003-2829-4226 0000-0002-1685-783X 0000-0002-6799-1561 0000-0003-4867-5544 0000-0003-2226-8916 0000-0002-5740-1505 0000-0002-0178-7744 0000-0003-1866-0800 0000-0002-0598-5684 |
OpenAccessLink | https://doaj.org/article/513393f0f35649aca846061a3bf65b23 |
PMID | 38107297 |
PQID | 2903325603 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_513393f0f35649aca846061a3bf65b23 proquest_miscellaneous_3153781440 proquest_miscellaneous_2903325603 pubmed_primary_38107297 crossref_citationtrail_10_1016_j_heliyon_2023_e22436 crossref_primary_10_1016_j_heliyon_2023_e22436 elsevier_sciencedirect_doi_10_1016_j_heliyon_2023_e22436 |
PublicationCentury | 2000 |
PublicationDate | December 2023 2023-12-00 2023-Dec 20231201 2023-12-01 |
PublicationDateYYYYMMDD | 2023-12-01 |
PublicationDate_xml | – month: 12 year: 2023 text: December 2023 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Heliyon |
PublicationTitleAlternate | Heliyon |
PublicationYear | 2023 |
Publisher | Elsevier Ltd Elsevier |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
References | Mannsverk (bib34) 2022; 19 Chan (bib9) 2022; 12 Tamura (bib38) 2023; 14 Verghese (bib28) 2021; 59 Shao (bib46) 2023; 29 Gruca (bib35) 2021; 22 Lin (bib10) 2022; 38 Gu (bib19) 2022; 28 Hsueh, Yang (bib1) 2005; 38 Berec (bib40) 2023; 43 Li (bib31) 2022; 38 Wilkinson (bib20) 2021; 374 Robishaw (bib7) 2021; 2 Tonkin-Hill (bib32) 2021 Subramoney (bib45) 2023; 15 Dong, Du, Gardner (bib3) 2020; 20 Wen (bib24) 2010; 14 Ku (bib8) 2022 Lamarca (bib6) 2021; 15 Dyer (bib16) 2022; 376 Sutton (bib22) 2022; 28 Yen (bib2) 2021; 110 Grimaldi (bib43) 2022; 14 Pozo-Martin (bib39) 2023; 38 Normile (bib17) 2022; 376 Chen (bib18) 2022; 54 Cheng (bib29) 2021; 12 Bennett (bib25) 2003; 20 Jian (bib26) 2021; 14 Grad, Lipsitch (bib42) 2014; 15 Fung (bib37) 2022; 12 Pitsillou (bib36) 2022; 114 Akhmetzhanov (bib15) 2022; 28 Subissi (bib30) 2022; 28 Tai (bib13) 2022 Ng (bib33) 2021; 181 Gong (bib21) 2020; 9 Wolf (bib44) 2023; 95 Kao (bib23) 2012; 7 Yang (bib11) 2020; 21 Davies (bib5) 2021 Obermeyer (bib4) 2022; 376 Pan (bib27) 2021; 15 Liu (bib12) 2021 Liu (bib14) 2022; 9 Ko (bib41) 2018; 12 Jian (10.1016/j.heliyon.2023.e22436_bib26) 2021; 14 Wolf (10.1016/j.heliyon.2023.e22436_bib44) 2023; 95 Obermeyer (10.1016/j.heliyon.2023.e22436_bib4) 2022; 376 Lin (10.1016/j.heliyon.2023.e22436_bib10) 2022; 38 Dong (10.1016/j.heliyon.2023.e22436_bib3) 2020; 20 Ng (10.1016/j.heliyon.2023.e22436_bib33) 2021; 181 Gruca (10.1016/j.heliyon.2023.e22436_bib35) 2021; 22 Wen (10.1016/j.heliyon.2023.e22436_bib24) 2010; 14 Grimaldi (10.1016/j.heliyon.2023.e22436_bib43) 2022; 14 Tonkin-Hill (10.1016/j.heliyon.2023.e22436_bib32) 2021 Ku (10.1016/j.heliyon.2023.e22436_bib8) 2022 Li (10.1016/j.heliyon.2023.e22436_bib31) 2022; 38 Wilkinson (10.1016/j.heliyon.2023.e22436_bib20) 2021; 374 Subissi (10.1016/j.heliyon.2023.e22436_bib30) 2022; 28 Kao (10.1016/j.heliyon.2023.e22436_bib23) 2012; 7 Chan (10.1016/j.heliyon.2023.e22436_bib9) 2022; 12 Shao (10.1016/j.heliyon.2023.e22436_bib46) 2023; 29 Akhmetzhanov (10.1016/j.heliyon.2023.e22436_bib15) 2022; 28 Grad (10.1016/j.heliyon.2023.e22436_bib42) 2014; 15 Cheng (10.1016/j.heliyon.2023.e22436_bib29) 2021; 12 Ko (10.1016/j.heliyon.2023.e22436_bib41) 2018; 12 Pozo-Martin (10.1016/j.heliyon.2023.e22436_bib39) 2023; 38 Berec (10.1016/j.heliyon.2023.e22436_bib40) 2023; 43 Yen (10.1016/j.heliyon.2023.e22436_bib2) 2021; 110 Liu (10.1016/j.heliyon.2023.e22436_bib14) 2022; 9 Fung (10.1016/j.heliyon.2023.e22436_bib37) 2022; 12 Lamarca (10.1016/j.heliyon.2023.e22436_bib6) 2021; 15 Normile (10.1016/j.heliyon.2023.e22436_bib17) 2022; 376 Gong (10.1016/j.heliyon.2023.e22436_bib21) 2020; 9 Hsueh (10.1016/j.heliyon.2023.e22436_bib1) 2005; 38 Tamura (10.1016/j.heliyon.2023.e22436_bib38) 2023; 14 Liu (10.1016/j.heliyon.2023.e22436_bib12) 2021 Dyer (10.1016/j.heliyon.2023.e22436_bib16) 2022; 376 Pitsillou (10.1016/j.heliyon.2023.e22436_bib36) 2022; 114 Yang (10.1016/j.heliyon.2023.e22436_bib11) 2020; 21 Bennett (10.1016/j.heliyon.2023.e22436_bib25) 2003; 20 Davies (10.1016/j.heliyon.2023.e22436_bib5) 2021 Gu (10.1016/j.heliyon.2023.e22436_bib19) 2022; 28 Mannsverk (10.1016/j.heliyon.2023.e22436_bib34) 2022; 19 Verghese (10.1016/j.heliyon.2023.e22436_bib28) 2021; 59 Sutton (10.1016/j.heliyon.2023.e22436_bib22) 2022; 28 Chen (10.1016/j.heliyon.2023.e22436_bib18) 2022; 54 Robishaw (10.1016/j.heliyon.2023.e22436_bib7) 2021; 2 Tai (10.1016/j.heliyon.2023.e22436_bib13) 2022 Pan (10.1016/j.heliyon.2023.e22436_bib27) 2021; 15 Subramoney (10.1016/j.heliyon.2023.e22436_bib45) 2023; 15 |
References_xml | – volume: 110 start-page: 469 year: 2021 end-page: 478 ident: bib2 article-title: Learning from the past: Taiwan's responses to COVID-19 versus SARS publication-title: Int. J. Infect. Dis. – volume: 38 start-page: 243 year: 2023 end-page: 266 ident: bib39 article-title: Comparative effectiveness of contact tracing interventions in the context of the COVID-19 pandemic: a systematic review publication-title: Eur. J. Epidemiol. – year: 2021 ident: bib12 article-title: Taiwan CDC MOHW110-CDC-C-315-124116 Report: Pathogen Analysis of Pneumonic Encephalitis and Unexplained Infectious Diseases – volume: 14 start-page: 90 year: 2022 ident: bib43 article-title: Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients publication-title: Genome Med. – volume: 9 year: 2022 ident: bib14 article-title: Identification and analysis of SARS-CoV-2 alpha variants in the largest Taiwan COVID-19 outbreak in 2021 publication-title: Front. Med. (Lausanne) – volume: 114 year: 2022 ident: bib36 article-title: The SARS-CoV-2 helicase as a target for antiviral therapy: identification of potential small molecule inhibitors by in silico modelling publication-title: J. Mol. Graph. Model. – volume: 54 start-page: 499 year: 2022 end-page: 507 ident: bib18 article-title: Global landscape of SARS-CoV-2 genomic surveillance and data sharing publication-title: Nat. Genet. – volume: 28 start-page: 247 year: 2022 end-page: 250 ident: bib19 article-title: Monitoring international travelers arriving in Hong Kong for genomic surveillance of SARS-CoV-2 publication-title: Emerg. Infect. Dis. – volume: 28 start-page: 1101 year: 2022 end-page: 1109 ident: bib22 article-title: Detection of SARS-CoV-2 B.1.351 (Beta) variant through wastewater surveillance before case detection in a community, Oregon, USA publication-title: Emerg. Infect. Dis. – volume: 14 start-page: 2800 year: 2023 ident: bib38 article-title: Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants publication-title: Nat. Commun. – volume: 20 start-page: 533 year: 2020 end-page: 534 ident: bib3 article-title: An interactive web-based dashboard to track COVID-19 in real time publication-title: Lancet Infect. Dis. – year: 2022 ident: bib8 article-title: Record of Resilience: Documenting Taipei's Pandemic Response – volume: 20 start-page: 1650 year: 2003 end-page: 1658 ident: bib25 article-title: Selection-driven evolution of emergent dengue virus publication-title: Mol. Biol. Evol. – volume: 21 start-page: 316 year: 2020 ident: bib11 article-title: FluConvert and IniFlu: a suite of integrated software to identify novel signatures of emerging influenza viruses with increasing risk publication-title: BMC Bioinf. – year: 2022 ident: bib13 article-title: Spatial and Temporal Origin of the Third SARS-COV-2 Outbreak in Taiwan – volume: 15 year: 2023 ident: bib45 article-title: Molecular epidemiology of SARS-CoV-2 during five COVID-19 waves and the significance of low-frequency lineages publication-title: Viruses – volume: 376 start-page: 1327 year: 2022 end-page: 1332 ident: bib4 article-title: Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness publication-title: Science – volume: 15 year: 2021 ident: bib27 article-title: Use of seroprevalence to guide dengue vaccination plans for older adults in a dengue non-endemic country publication-title: PLoS Neglected Trop. Dis. – volume: 28 start-page: 1110 year: 2022 end-page: 1115 ident: bib30 article-title: An early warning system for emerging SARS-CoV-2 variants publication-title: Nat. Med. – volume: 2 start-page: e481 year: 2021 end-page: e484 ident: bib7 article-title: Genomic surveillance to combat COVID-19: challenges and opportunities publication-title: Lancet Microbe – volume: 15 year: 2021 ident: bib6 article-title: Genomic surveillance of SARS-CoV-2 tracks early interstate transmission of P.1 lineage and diversification within P.2 clade in Brazil publication-title: PLoS Neglected Trop. Dis. – start-page: 10 year: 2021 ident: bib32 article-title: Patterns of within-host genetic diversity in SARS-CoV-2 publication-title: Elife – volume: 376 start-page: o859 year: 2022 ident: bib16 article-title: Covid-19: lockdowns spread in China as omicron tests "zero covid" strategy publication-title: BMJ – volume: 12 year: 2021 ident: bib29 article-title: D614G substitution of SARS-CoV-2 spike protein increases syncytium formation and virus titer via enhanced furin-mediated spike Cleavage publication-title: mBio – volume: 12 year: 2018 ident: bib41 article-title: Inter- and intra-host sequence diversity reveal the emergence of viral variants during an overwintering epidemic caused by dengue virus serotype 2 in southern Taiwan publication-title: PLoS Neglected Trop. Dis. – volume: 38 year: 2022 ident: bib31 article-title: Two-step fitness selection for intra-host variations in SARS-CoV-2 publication-title: Cell Rep. – volume: 28 start-page: 2051 year: 2022 end-page: 2059 ident: bib15 article-title: Transmission dynamics and effectiveness of control measures during COVID-19 surge, Taiwan, April-August 2021 publication-title: Emerg. Infect. Dis. – volume: 376 start-page: 333 year: 2022 end-page: 334 ident: bib17 article-title: China refuses to end harsh lockdowns publication-title: Science – volume: 9 start-page: 1457 year: 2020 end-page: 1466 ident: bib21 article-title: SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East publication-title: Emerg. Microb. Infect. – volume: 95 year: 2023 ident: bib44 article-title: Molecular evolution of SARS-CoV-2 from december 2019 to August 2022 publication-title: J. Med. Virol. – volume: 12 year: 2022 ident: bib9 article-title: Effectiveness of controlling COVID-19 epidemic by implementing soft lockdown policy and extensive community screening in Taiwan publication-title: Sci. Rep. – volume: 38 start-page: 208 year: 2022 end-page: 214 ident: bib10 article-title: Investigation of the COVID-19 Cluster events at an agricultural products marketing company in Northern Taiwan in 2021 publication-title: Taiwan Epidemiol. Bull. – start-page: 372 year: 2021 ident: bib5 article-title: Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England publication-title: Science – volume: 12 start-page: 36 year: 2022 ident: bib37 article-title: SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1 publication-title: Cell Biosci. – volume: 14 start-page: e334 year: 2010 end-page: e343 ident: bib24 article-title: Spatial-temporal patterns of dengue in areas at risk of dengue hemorrhagic fever in Kaohsiung, Taiwan, 2002 publication-title: Int. J. Infect. Dis. – volume: 29 start-page: 792 year: 2023 end-page: 796 ident: bib46 article-title: Emergence and persistent dominance of SARS-CoV-2 omicron BA.2.3.7 variant, Taiwan publication-title: Emerg. Infect. Dis. – volume: 59 year: 2021 ident: bib28 article-title: A SARS-CoV-2 variant with L452R and E484Q neutralization resistance mutations publication-title: J. Clin. Microbiol. – volume: 7 year: 2012 ident: bib23 article-title: Emerged HA and NA mutants of the pandemic influenza H1N1 viruses with increasing epidemiological significance in Taipei and Kaohsiung, Taiwan, 2009-10 publication-title: PLoS One – volume: 38 start-page: 82 year: 2005 end-page: 88 ident: bib1 article-title: Severe acute respiratory syndrome epidemic in Taiwan, 2003 publication-title: J. Microbiol. Immunol. Infect. – volume: 374 start-page: 423 year: 2021 end-page: 431 ident: bib20 article-title: A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa publication-title: Science – volume: 43 year: 2023 ident: bib40 article-title: On the contact tracing for COVID-19: a simulation study publication-title: Epidemics – volume: 181 start-page: 913 year: 2021 end-page: 921 ident: bib33 article-title: Comparison of estimated effectiveness of case-based and population-based interventions on COVID-19 containment in Taiwan publication-title: JAMA Intern. Med. – volume: 22 start-page: 182 year: 2021 ident: bib35 article-title: Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development publication-title: BMC Bioinf. – volume: 19 start-page: 164 year: 2022 ident: bib34 article-title: SARS-CoV-2 variants of concern and spike protein mutational dynamics in a Swedish cohort during 2021, studied by Nanopore sequencing publication-title: Virol. J. – volume: 15 start-page: 538 year: 2014 ident: bib42 article-title: Epidemiologic data and pathogen genome sequences: a powerful synergy for public health publication-title: Genome Biol. – volume: 14 start-page: 3255 year: 2021 end-page: 3261 ident: bib26 article-title: Clinical comparison of three sample-to-answer systems for detecting SARS-CoV-2 in B.1.1.7 lineage emergence publication-title: Infect. Drug Resist. – year: 2021 ident: 10.1016/j.heliyon.2023.e22436_bib12 – volume: 374 start-page: 423 issue: 6566 year: 2021 ident: 10.1016/j.heliyon.2023.e22436_bib20 article-title: A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa publication-title: Science doi: 10.1126/science.abj4336 – volume: 181 start-page: 913 issue: 7 year: 2021 ident: 10.1016/j.heliyon.2023.e22436_bib33 article-title: Comparison of estimated effectiveness of case-based and population-based interventions on COVID-19 containment in Taiwan publication-title: JAMA Intern. Med. doi: 10.1001/jamainternmed.2021.1644 – volume: 59 issue: 7 year: 2021 ident: 10.1016/j.heliyon.2023.e22436_bib28 article-title: A SARS-CoV-2 variant with L452R and E484Q neutralization resistance mutations publication-title: J. Clin. Microbiol. doi: 10.1128/JCM.00741-21 – volume: 15 issue: 5 year: 2023 ident: 10.1016/j.heliyon.2023.e22436_bib45 article-title: Molecular epidemiology of SARS-CoV-2 during five COVID-19 waves and the significance of low-frequency lineages publication-title: Viruses doi: 10.3390/v15051194 – start-page: 10 year: 2021 ident: 10.1016/j.heliyon.2023.e22436_bib32 article-title: Patterns of within-host genetic diversity in SARS-CoV-2 publication-title: Elife – volume: 43 year: 2023 ident: 10.1016/j.heliyon.2023.e22436_bib40 article-title: On the contact tracing for COVID-19: a simulation study publication-title: Epidemics doi: 10.1016/j.epidem.2023.100677 – year: 2022 ident: 10.1016/j.heliyon.2023.e22436_bib8 – year: 2022 ident: 10.1016/j.heliyon.2023.e22436_bib13 – volume: 114 year: 2022 ident: 10.1016/j.heliyon.2023.e22436_bib36 article-title: The SARS-CoV-2 helicase as a target for antiviral therapy: identification of potential small molecule inhibitors by in silico modelling publication-title: J. Mol. Graph. Model. doi: 10.1016/j.jmgm.2022.108193 – volume: 12 start-page: 36 issue: 1 year: 2022 ident: 10.1016/j.heliyon.2023.e22436_bib37 article-title: SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1 publication-title: Cell Biosci. doi: 10.1186/s13578-022-00770-1 – volume: 20 start-page: 533 issue: 5 year: 2020 ident: 10.1016/j.heliyon.2023.e22436_bib3 article-title: An interactive web-based dashboard to track COVID-19 in real time publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(20)30120-1 – volume: 376 start-page: 1327 issue: 6599 year: 2022 ident: 10.1016/j.heliyon.2023.e22436_bib4 article-title: Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness publication-title: Science doi: 10.1126/science.abm1208 – volume: 28 start-page: 247 issue: 1 year: 2022 ident: 10.1016/j.heliyon.2023.e22436_bib19 article-title: Monitoring international travelers arriving in Hong Kong for genomic surveillance of SARS-CoV-2 publication-title: Emerg. Infect. Dis. doi: 10.3201/eid2801.211804 – volume: 376 start-page: 333 issue: 6591 year: 2022 ident: 10.1016/j.heliyon.2023.e22436_bib17 article-title: China refuses to end harsh lockdowns publication-title: Science doi: 10.1126/science.abq6109 – volume: 38 start-page: 243 issue: 3 year: 2023 ident: 10.1016/j.heliyon.2023.e22436_bib39 article-title: Comparative effectiveness of contact tracing interventions in the context of the COVID-19 pandemic: a systematic review publication-title: Eur. J. Epidemiol. doi: 10.1007/s10654-023-00963-z – volume: 28 start-page: 2051 issue: 10 year: 2022 ident: 10.1016/j.heliyon.2023.e22436_bib15 article-title: Transmission dynamics and effectiveness of control measures during COVID-19 surge, Taiwan, April-August 2021 publication-title: Emerg. Infect. Dis. doi: 10.3201/eid2810.220456 – volume: 14 start-page: e334 issue: 4 year: 2010 ident: 10.1016/j.heliyon.2023.e22436_bib24 article-title: Spatial-temporal patterns of dengue in areas at risk of dengue hemorrhagic fever in Kaohsiung, Taiwan, 2002 publication-title: Int. J. Infect. Dis. doi: 10.1016/j.ijid.2009.06.006 – volume: 38 start-page: 82 issue: 2 year: 2005 ident: 10.1016/j.heliyon.2023.e22436_bib1 article-title: Severe acute respiratory syndrome epidemic in Taiwan, 2003 publication-title: J. Microbiol. Immunol. Infect. – volume: 54 start-page: 499 issue: 4 year: 2022 ident: 10.1016/j.heliyon.2023.e22436_bib18 article-title: Global landscape of SARS-CoV-2 genomic surveillance and data sharing publication-title: Nat. Genet. doi: 10.1038/s41588-022-01033-y – volume: 7 issue: 2 year: 2012 ident: 10.1016/j.heliyon.2023.e22436_bib23 article-title: Emerged HA and NA mutants of the pandemic influenza H1N1 viruses with increasing epidemiological significance in Taipei and Kaohsiung, Taiwan, 2009-10 publication-title: PLoS One doi: 10.1371/journal.pone.0031162 – volume: 28 start-page: 1101 issue: 6 year: 2022 ident: 10.1016/j.heliyon.2023.e22436_bib22 article-title: Detection of SARS-CoV-2 B.1.351 (Beta) variant through wastewater surveillance before case detection in a community, Oregon, USA publication-title: Emerg. Infect. Dis. doi: 10.3201/eid2806.211821 – volume: 110 start-page: 469 year: 2021 ident: 10.1016/j.heliyon.2023.e22436_bib2 article-title: Learning from the past: Taiwan's responses to COVID-19 versus SARS publication-title: Int. J. Infect. Dis. doi: 10.1016/j.ijid.2021.06.002 – volume: 15 issue: 4 year: 2021 ident: 10.1016/j.heliyon.2023.e22436_bib27 article-title: Use of seroprevalence to guide dengue vaccination plans for older adults in a dengue non-endemic country publication-title: PLoS Neglected Trop. Dis. doi: 10.1371/journal.pntd.0009312 – volume: 21 start-page: 316 issue: 1 year: 2020 ident: 10.1016/j.heliyon.2023.e22436_bib11 article-title: FluConvert and IniFlu: a suite of integrated software to identify novel signatures of emerging influenza viruses with increasing risk publication-title: BMC Bioinf. doi: 10.1186/s12859-020-03650-y – volume: 12 issue: 4 year: 2021 ident: 10.1016/j.heliyon.2023.e22436_bib29 article-title: D614G substitution of SARS-CoV-2 spike protein increases syncytium formation and virus titer via enhanced furin-mediated spike Cleavage publication-title: mBio doi: 10.1128/mBio.00587-21 – volume: 15 issue: 10 year: 2021 ident: 10.1016/j.heliyon.2023.e22436_bib6 article-title: Genomic surveillance of SARS-CoV-2 tracks early interstate transmission of P.1 lineage and diversification within P.2 clade in Brazil publication-title: PLoS Neglected Trop. Dis. doi: 10.1371/journal.pntd.0009835 – volume: 14 start-page: 90 issue: 1 year: 2022 ident: 10.1016/j.heliyon.2023.e22436_bib43 article-title: Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients publication-title: Genome Med. doi: 10.1186/s13073-022-01098-8 – volume: 9 start-page: 1457 issue: 1 year: 2020 ident: 10.1016/j.heliyon.2023.e22436_bib21 article-title: SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East publication-title: Emerg. Microb. Infect. doi: 10.1080/22221751.2020.1782271 – volume: 22 start-page: 182 issue: 1 year: 2021 ident: 10.1016/j.heliyon.2023.e22436_bib35 article-title: Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development publication-title: BMC Bioinf. doi: 10.1186/s12859-021-04017-7 – volume: 12 issue: 1 year: 2022 ident: 10.1016/j.heliyon.2023.e22436_bib9 article-title: Effectiveness of controlling COVID-19 epidemic by implementing soft lockdown policy and extensive community screening in Taiwan publication-title: Sci. Rep. doi: 10.1038/s41598-022-16011-x – volume: 20 start-page: 1650 issue: 10 year: 2003 ident: 10.1016/j.heliyon.2023.e22436_bib25 article-title: Selection-driven evolution of emergent dengue virus publication-title: Mol. Biol. Evol. doi: 10.1093/molbev/msg182 – volume: 14 start-page: 2800 issue: 1 year: 2023 ident: 10.1016/j.heliyon.2023.e22436_bib38 article-title: Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants publication-title: Nat. Commun. doi: 10.1038/s41467-023-38435-3 – volume: 38 start-page: 208 issue: 16 year: 2022 ident: 10.1016/j.heliyon.2023.e22436_bib10 article-title: Investigation of the COVID-19 Cluster events at an agricultural products marketing company in Northern Taiwan in 2021 publication-title: Taiwan Epidemiol. Bull. – volume: 14 start-page: 3255 year: 2021 ident: 10.1016/j.heliyon.2023.e22436_bib26 article-title: Clinical comparison of three sample-to-answer systems for detecting SARS-CoV-2 in B.1.1.7 lineage emergence publication-title: Infect. Drug Resist. doi: 10.2147/IDR.S328327 – volume: 15 start-page: 538 issue: 11 year: 2014 ident: 10.1016/j.heliyon.2023.e22436_bib42 article-title: Epidemiologic data and pathogen genome sequences: a powerful synergy for public health publication-title: Genome Biol. doi: 10.1186/s13059-014-0538-4 – volume: 95 issue: 1 year: 2023 ident: 10.1016/j.heliyon.2023.e22436_bib44 article-title: Molecular evolution of SARS-CoV-2 from december 2019 to August 2022 publication-title: J. Med. Virol. doi: 10.1002/jmv.28366 – start-page: 372 issue: 6538 year: 2021 ident: 10.1016/j.heliyon.2023.e22436_bib5 article-title: Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England publication-title: Science – volume: 9 year: 2022 ident: 10.1016/j.heliyon.2023.e22436_bib14 article-title: Identification and analysis of SARS-CoV-2 alpha variants in the largest Taiwan COVID-19 outbreak in 2021 publication-title: Front. Med. (Lausanne) – volume: 2 start-page: e481 issue: 9 year: 2021 ident: 10.1016/j.heliyon.2023.e22436_bib7 article-title: Genomic surveillance to combat COVID-19: challenges and opportunities publication-title: Lancet Microbe doi: 10.1016/S2666-5247(21)00121-X – volume: 38 issue: 2 year: 2022 ident: 10.1016/j.heliyon.2023.e22436_bib31 article-title: Two-step fitness selection for intra-host variations in SARS-CoV-2 publication-title: Cell Rep. doi: 10.1016/j.celrep.2021.110205 – volume: 376 start-page: o859 year: 2022 ident: 10.1016/j.heliyon.2023.e22436_bib16 article-title: Covid-19: lockdowns spread in China as omicron tests "zero covid" strategy publication-title: BMJ doi: 10.1136/bmj.o859 – volume: 12 issue: 10 year: 2018 ident: 10.1016/j.heliyon.2023.e22436_bib41 article-title: Inter- and intra-host sequence diversity reveal the emergence of viral variants during an overwintering epidemic caused by dengue virus serotype 2 in southern Taiwan publication-title: PLoS Neglected Trop. Dis. doi: 10.1371/journal.pntd.0006827 – volume: 28 start-page: 1110 issue: 6 year: 2022 ident: 10.1016/j.heliyon.2023.e22436_bib30 article-title: An early warning system for emerging SARS-CoV-2 variants publication-title: Nat. Med. doi: 10.1038/s41591-022-01836-w – volume: 29 start-page: 792 issue: 4 year: 2023 ident: 10.1016/j.heliyon.2023.e22436_bib46 article-title: Emergence and persistent dominance of SARS-CoV-2 omicron BA.2.3.7 variant, Taiwan publication-title: Emerg. Infect. Dis. doi: 10.3201/eid2904.221497 – volume: 19 start-page: 164 issue: 1 year: 2022 ident: 10.1016/j.heliyon.2023.e22436_bib34 article-title: SARS-CoV-2 variants of concern and spike protein mutational dynamics in a Swedish cohort during 2021, studied by Nanopore sequencing publication-title: Virol. J. doi: 10.1186/s12985-022-01896-x |
SSID | ssj0001586973 |
Score | 2.247177 |
Snippet | Taiwan’s experience with severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 guided its development of strategies to defend against SARS-CoV-2 in... Taiwan's experience with severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 guided its development of strategies to defend against SARS-CoV-2 in... |
SourceID | doaj proquest pubmed crossref elsevier |
SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e22436 |
SubjectTerms | Bioinformatics Community outbreak computer software COVID-19 infection decline Epicenter issues and policy public health Reproduction number SARS-CoV-2 Severe acute respiratory syndrome coronavirus Severe acute respiratory syndrome coronavirus 2 Spatio-temporal analysis Taiwan Transmission vaccination Viral variants viruses Whole-genome sequencing |
Title | The emergence and successful elimination of SARS-CoV-2 dominant strains with increasing epidemic potential in Taiwan’s 2021 outbreak |
URI | https://dx.doi.org/10.1016/j.heliyon.2023.e22436 https://www.ncbi.nlm.nih.gov/pubmed/38107297 https://www.proquest.com/docview/2903325603 https://www.proquest.com/docview/3153781440 https://doaj.org/article/513393f0f35649aca846061a3bf65b23 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQKyEuiPJcCpWRuHqbjR9JjkvVqqIqhz6gN8tObJF2lVQkEeqNE_-Bv8cv6Yyd3ZZDtReukZPYnrG-z_bMN4R8FHmRyaziLBfCMwGMgxXOJCzzCth2CggYMryPv6jDc_H5Ql7cK_WFMWFRHjhO3C7WHym4TzyXShSmNACYgEGGW6-kTYPOJ2Devc1UzA_OVZHxu5Sd3cvpd7eob1rUPE351AF0BVnmOzAKmv3_YNJDnDNgz8Ez8nQkjXQeO7tFHrnmOXl8PF6LvyC_wdjUjYmUjpqmot0QKiH6YUGhQxjvghagraen85NTttd-ZSmt2hgIQ7tQKaKjeCpL6waZJJ4hUBfrx5b0uu0xrAg6UTf0zNQ_TfP315-OwihntB162Fibq5fk_GD_bO-QjQUWWAk8q2coNpZJgRJo0lZJaXwCWAUcoxBe8VI6K00x41VWFWnifYXy6xZMaBNZzryy_BXZaNrGvSHUcSdyM3OZAw6YG2MV50biLWIlKpWnEyKWM63LUX0ch7bQyzCzSz0aSKOBdDTQhExXr11H-Y11L3xCM64ao3p2eAA-pUef0ut8akLypRPokYhEggGfqtf9_8PSaTQsVLx9MY1rh06nRcI5Ekz-cBsO-IMaZCKZkNfR41YjQSk22Allb__HCLfJE-x0jMt5Rzb6H4N7D-yqtztkc3508u1oJyyoWzRpIeU |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+emergence+and+successful+elimination+of+SARS-CoV-2+dominant+strains+with+increasing+epidemic+potential+in+Taiwan%27s+2021+outbreak&rft.jtitle=Heliyon&rft.au=Yang%2C+Chin-Rur&rft.au=Chang%2C+Sui-Yuan&rft.au=Gong%2C+Yu-Nong&rft.au=Huang%2C+Chung-Guei&rft.date=2023-12-01&rft.issn=2405-8440&rft.eissn=2405-8440&rft.volume=9&rft.issue=12&rft.spage=e22436&rft_id=info:doi/10.1016%2Fj.heliyon.2023.e22436&rft_id=info%3Apmid%2F38107297&rft.externalDocID=38107297 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2405-8440&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2405-8440&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2405-8440&client=summon |